Health Care

Marksans Pharma (NSE:MARKSANS) is a mid-sized pharmaceutical company with a large presence in the US, UK, Australia, and New Zealand…

“The second quarter saw a healthy improvement in the demand for Non-COVID business across all segments. The Company managed to…

Shalby Ltd.‘s revenues in Q2FY23 rose 11% to ₹ 2,018 millions. Consolidated Profit After Tax came at ₹ 184 millions…

“With all key strategies in place, our team is extremely committed to flawless execution of these strategies. Shalby is very…

Would you buy the stocks of the company that is loaded in debt, entangled in legal battles and generating crores…

Key highlights from Marksans Pharma Limited (MARKSANS) Q2 FY23 Earnings Concall Q&A Highlights: [00:12:45] Madhav Shastri asked about the new…

Key highlights from Orchid Pharma Ltd (ORCHPHARMA) Q2 FY23 Earnings Concall Q&A Highlights: [00:05:20] Rupesh Jain from Intelsense Capital asked…

Key highlights from IOL Chemicals and Pharmaceuticals Limited (IOLCP) Q2 FY23 Earnings Concall Q&A Highlights: [00:12:26] Venkat of 3Sigma Financials…

Key highlights from Aarti Industries Ltd (AARTIIND) Q2 FY23 Earnings Concall Management Update: [00:03:50] AARTIIND said it is seeing slower…

Brooks Laboratories Limited(NSE:BROOKS) has an industry presence of nearly two decades now, leading to established relationships with the customers as…